ACCESS PHARMACEUTICALS, INC.

Company

ABEONA THERAPEUTICS INC.

Filed

October 9, 2001

Accession Number

0000940180-01-500327

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →